KKR & Co. Inc. (NYSE:KKR) Receives New Coverage from Analysts at HSBC

HSBC began coverage on shares of KKR & Co. Inc. (NYSE:KKR) in a research note published on Wednesday, MarketBeat.com reports. The brokerage issued a buy rating and a $148.00 price target on the asset manager’s stock.

A number of other research firms have also weighed in on KKR. Citigroup lifted their target price on KKR & Co. Inc. from $130.00 to $150.00 and gave the company a buy rating in a report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft lifted their target price on KKR & Co. Inc. from $128.00 to $141.00 and gave the company a buy rating in a report on Thursday, August 1st. Oppenheimer lifted their target price on KKR & Co. Inc. from $121.00 to $128.00 and gave the company an outperform rating in a report on Thursday, August 1st. Keefe, Bruyette & Woods reaffirmed an outperform rating and set a $144.00 target price (up previously from $125.00) on shares of KKR & Co. Inc. in a report on Thursday, August 1st. Finally, Redburn Atlantic assumed coverage on KKR & Co. Inc. in a report on Tuesday, August 27th. They set a buy rating and a $153.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, KKR & Co. Inc. presently has an average rating of Moderate Buy and an average target price of $128.27.

KKR & Co. Inc. Trading Up 1.0 %

Shares of KKR opened at $129.25 on Wednesday. The business has a 50-day moving average of $117.93 and a 200 day moving average of $107.33. KKR & Co. Inc. has a fifty-two week low of $53.72 and a fifty-two week high of $130.93. The firm has a market cap of $114.70 billion, a P/E ratio of 28.98, a price-to-earnings-growth ratio of 0.99 and a beta of 1.62. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.07 and a current ratio of 0.07.

KKR & Co. Inc. (NYSE:KKR) last posted its earnings results on Wednesday, July 31st. The asset manager reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $0.89 by $0.20. The business had revenue of $4.17 billion during the quarter, compared to analyst estimates of $1.07 billion. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. During the same quarter in the previous year, the firm earned $0.58 EPS. As a group, research analysts forecast that KKR & Co. Inc. will post 4.01 EPS for the current year.

KKR & Co. Inc. Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Monday, August 12th were given a $0.175 dividend. The ex-dividend date of this dividend was Monday, August 12th. This represents a $0.70 dividend on an annualized basis and a yield of 0.54%. KKR & Co. Inc.’s payout ratio is 15.70%.

Insider Buying and Selling

In related news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the sale, the insider now owns 25,260,971 shares in the company, valued at approximately $650,470,003.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, major shareholder Kkr Group Partnership L.P. acquired 11,619,998 shares of the stock in a transaction on Wednesday, September 11th. The stock was purchased at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the completion of the transaction, the insider now owns 92,959,984 shares of the company’s stock, valued at approximately $1,034,644,621.92. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the business’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. The disclosure for this sale can be found here. 39.34% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On KKR & Co. Inc.

Several hedge funds have recently made changes to their positions in KKR. Riverview Trust Co purchased a new position in shares of KKR & Co. Inc. during the first quarter valued at approximately $27,000. Versant Capital Management Inc increased its stake in shares of KKR & Co. Inc. by 622.9% during the second quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock valued at $27,000 after buying an additional 218 shares during the period. Mather Group LLC. increased its stake in shares of KKR & Co. Inc. by 371.4% during the second quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock valued at $27,000 after buying an additional 208 shares during the period. American National Bank increased its stake in shares of KKR & Co. Inc. by 202.6% during the second quarter. American National Bank now owns 351 shares of the asset manager’s stock valued at $37,000 after buying an additional 235 shares during the period. Finally, Farmers & Merchants Investments Inc. purchased a new position in shares of KKR & Co. Inc. during the second quarter valued at approximately $38,000. 76.26% of the stock is owned by hedge funds and other institutional investors.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.